Beijing Tiantan Biological Products Co., Ltd.
600161
Rang in Aktien
#4319
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and... Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.
Aktienkurs
$1.81
Marktkapitalisierung
$3.59B
Veränderung (1 Tag)
-0.90%
Veränderung (1 Jahr)
-32.39%
Land
CN
Handel Beijing Tiantan Biological Products Co., Ltd. (600161)
Kategorie
Healthcare
Kursverlauf für Beijing Tiantan Biological Products Co., Ltd. (600161)
Höchster Schlusskurs: $1.81 am 2026-10-01
Niedrigster Schlusskurs: $0.07 am 2005-07-01
Niedrigster Schlusskurs: $0.07 am 2005-07-01
Kursverlauf der Aktie von Beijing Tiantan Biological Products Co., Ltd. von 2005 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -10.60% |
| 2025 | -18.04% |
| 2024 | -20.40% |
| 2023 | 33.59% |
| 2022 | -13.56% |
| 2021 | -28.42% |
| 2020 | 98.85% |
| 2019 | 45.59% |
| 2018 | -15.66% |
| 2017 | 10.41% |
| 2016 | 19.78% |
| 2015 | 5.68% |
| 2014 | 24.08% |
| 2013 | 90.14% |
| 2012 | -27.39% |
| 2011 | -24.78% |
| 2010 | -11.65% |
| 2009 | 89.78% |
| 2008 | -47.45% |
| 2007 | 135.81% |
| 2006 | 373.09% |
| 2005 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $763.31 | 8.49% |
CH
|
